Lack of NOD2 attenuates ovariectomy-induced bone loss via inhibition of osteoclasts.

Nucleotide-binding oligomerization domain-2 (NOD2) is a pattern recognition receptor of the innate immune system. It interacts with serine-threonine kinases to induce activation of nuclear factor κB (NF-κB), which is important for receptor activator of nuclear factor kappa-B ligand (RANKL) signaling. We tested the idea that NOD2 modulates bone metabolism via an action on osteoclasts (OCs). The absence of NOD2 reduced ovariectomy-induced bone loss in mice, and lowered the area and the activity of OCs, by impairing RANKL signaling. It also reduced the level of reactive oxygen species (ROS), as well as of NF-κB-DNA binding upon RANKL exposure. NOD2 was found to physically interact with nicotinamide adenine dinucleotide phosphate oxidase 1, and this led to increased production of ROS in OCs. Our data suggest that NOD2 contributes to bone loss in estrogen deficiency by elevating ROS levels in OCs. © 2017 Society for Endocrinology.

Citation

Ke Ke, Ok-Joo Sul, Soo-Wol Chung, Jae-Hee Suh, Hye-Seon Choi. Lack of NOD2 attenuates ovariectomy-induced bone loss via inhibition of osteoclasts. The Journal of endocrinology. 2017 Nov;235(2):85-96

Mesh Tags

Substances

PMID: 28778866

search → result